| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |